Lite Strategy, Inc. Total Contract Liability
Lite Strategy, Inc. (LITS) had Total Contract Liability of $0 as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-09-26
- 2025-03-31: Contract with Customer, Liability $0.00.
- 2024-06-30: Contract with Customer, Liability $0.00.
- 2024-03-31: Contract with Customer, Liability $0.00.
- 2023-12-31: Contract with Customer, Liability $317.00K; Contract with Customer, Liability as first filed $0.00.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |
| 2024-06-30 | $0.00 10-K · filed 2025-09-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $317.00K 10-Q · filed 2024-05-09 | $0.00 10-Q · filed 2024-02-13 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $317.00K 10-K · filed 2025-09-26 | |
| 2023-03-31 | $1.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.90M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $29.93M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.90M 10-K · filed 2024-09-19 | |
| 2022-03-31 | $32.16M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $33.41M 10-Q · filed 2023-02-09 | $29.50M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $35.09M 10-Q · filed 2022-11-14 | $37.57M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $14.68M 10-K · filed 2023-09-26 | $22.78M 10-K · filed 2021-09-02 |
| 2021-03-31 | $14.57M 10-Q · filed 2022-05-23 | $89.88M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $15.21M 10-Q/A · filed 2022-05-23 | $84.83M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $17.64M 10-Q/A · filed 2022-05-23 | $83.84M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $19.11M 10-K · filed 2022-09-08 | $82.50M 10-K · filed 2020-09-09 |
| 2020-03-31 | $5.29M 10-Q · filed 2021-05-06 | $5.29M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.16M 10-Q · filed 2021-02-04 | |
| 2019-09-30 | $6.91M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $7.77M 10-K/A · filed 2022-05-23 | |
| 2019-03-31 | $8.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.14M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $740.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $788.00K 10-K · filed 2020-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |